PUMA BIOTECHNOLOGY, INC.

Nasdaq:PBYI

Pharmaceutical Preparations·LOS ANGELES, CA

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

CEO

Auerbach Alan H

CFO

Nougues Maximo F

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/26/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q/A	Q1 2025	3/31/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	2/27/25	→
↓

Earnings Releases (8-K)

29 shown

Filed	Period
2/26/26	Q1 FY2026	→
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
2/27/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

51 shown

Filed	Type	Description
6/24/25	Other	Amendments to Articles of Incorporation or Bylaws	→
6/13/25	Vote	Submission of Matters to a Vote of Security Holders	→
5/9/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/16/24	Other	Other Events	→
8/15/24	Other	Other Events	→
8/7/24	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
4/28/25	ARS	ARS	→
8/27/24	S-8	S-8	→
4/26/24	ARS	ARS	→
4/28/23	ARS	ARS	→
8/2/22	424B3	424B3	→
7/25/22	S-3	S-3	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

10-K

Feb 26, 2026

0001437749-26-005891FORM 10-K

Dec 31, 2025

10.7 MB

8-K

Feb 26, 2026

0001437749-26-005869FORM 8-K

Feb 26, 2026

400.8 KB

Feb 20, 2026

0001437749-26-004948FORM 4

Feb 18, 2026

7.2 KB

Feb 20, 2026

0001437749-26-004947FORM 4

Feb 18, 2026

7.2 KB

Feb 20, 2026

0001437749-26-004946FORM 4

Feb 18, 2026

7.1 KB

Jan 8, 2026

0001437749-26-000924FORM 4

Jan 6, 2026

5.9 KB

Jan 8, 2026

0001437749-26-000922FORM 4

Jan 6, 2026

5.9 KB

Jan 8, 2026

0001437749-26-000921FORM 4

Jan 6, 2026

5.9 KB

144

Jan 7, 2026

0001959173-26-000194

—

5.2 KB

144

Jan 7, 2026

0001959173-26-000193

—

5.1 KB

144

Jan 7, 2026

0001959173-26-000192

—

5.2 KB

144

Jan 6, 2026

0001959173-26-000171

—

4.5 KB

144

Jan 6, 2026

0001959173-26-000167

—

4.5 KB

144

Jan 6, 2026

0001959173-26-000165

—

4.5 KB

Nov 13, 2025

0001437749-25-034874FORM 4

Nov 11, 2025

5.1 KB

144

Nov 12, 2025

0001959173-25-006907

—

4.7 KB

10-Q

Nov 6, 2025

0001437749-25-033633FORM 10-Q

Sep 30, 2025

7.9 MB

8-K

Nov 6, 2025

0001437749-25-033604FORM 8-K

Nov 6, 2025

397.2 KB

10-Q

Aug 7, 2025

0001437749-25-025470FORM 10-Q

Jun 30, 2025

7.9 MB

8-K

Aug 7, 2025

0001437749-25-025463FORM 8-K

Aug 7, 2025

402.5 KB

10-Q/A

Aug 7, 2025

0001437749-25-025214FORM 10-Q/A

Mar 31, 2025

236.9 KB

Jul 22, 2025

0001437749-25-023268FORM 4

Jul 18, 2025

4.9 KB

144

Jul 18, 2025

0001959173-25-004647

—

5.1 KB

Jul 10, 2025

0001437749-25-022551FORM 4

Jul 8, 2025

5.9 KB

Jul 10, 2025

0001437749-25-022549FORM 4

Jul 8, 2025

6.0 KB

25 filings shown

PUMA BIOTECHNOLOGY, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
4/28/25	DEFA14A	FORM DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	FORM DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	FORM DEFA14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
2/20/26	4	4	→
2/20/26	4	4	→
2/20/26	4	4	→
1/8/26	4	4	→
1/8/26	4	4	→
1/8/26	4	4	→
↓

Filed	Form	Description
1/7/26	144	144	→
1/7/26	144	144	→
1/7/26	144	144	→
1/6/26	144	144	→
1/6/26	144	144	→
1/6/26	144	144	→
↓